Patrick Neven — Endo Lab

letter 2020

Uterine ultrasound and endometrial biopsy in tamoxifen users

·doi:10.1007/s10549-020-05595-5

article 2011

Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass

·doi:10.1097/gme.0b013e318223bbf4

OBJECTIVE: The aim of this study was to report the gynecologic safety findings from the Generations trial, a phase 3 study of the selective estrogen receptor modulator (SERM), arzoxifene. METHODS: A predefined objective of the trial was to …

letter 2006

Aromatase Inhibitors in Premenopausal Women: The Need for Proper Contraceptive Counseling

·doi:10.1111/j.1075-122x.2006.00318.x

review 2004

Endometriosis and the development of malignant tumours of the pelvis. A review of literature

Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2003.03.001

For several decades, endometriosis has been suspected of playing a role in the aetiology of ovarian cancer. The literature concerning a possible histogenesis of ovarian cancer from benign endometriosis is reviewed in this chapter. Epidemiol…

review 2002

Endometrial safety of hormone replacement therapy: review of literature

Maturitas ·doi:10.1016/s0378-5122(02)00031-2

Unopposed estrogens for treating menopausal symptoms were extensively used when epidemiological findings associated them with an increased endometrial cancer risk. Adding progestogens reverse this side effect efficiently but patient, dose, …

article 2000

Oestrogen and progesterone receptor expression in postmenopausal endometrial polyps and their surrounding endometrium

·doi:10.1016/s0959-8049(00)00263-x

article 1998

II.2 Tamoxifen and benign endometrial lesions

·doi:10.1016/s0959-8049(98)00091-4

article 1998

III.1 Tamoxifen and the uterus—the hysteroscopic approach

·doi:10.1016/s0959-8049(98)00098-7

letter 1994

Effects of tamoxifen on uterus

·doi:10.1016/s0140-6736(94)92013-3

article 1991

Endometrial lesions in patients undergoing tamoxifen therapy

·doi:10.1016/0020-7292(91)90767-y

Forty-six nonhysterectomized women treated with tamoxifen during 6-36 months as adjuvant therapy for breast cancer underwent a hysteroscopy to assess the endometrial effects of this drug. Whereas the endometrium was normal among 23 patients…

letter 1990

Endometrial hyperplasia in an oophorectomized woman receiving tamoxifen therapy

·doi:10.1111/j.1471-0528.1990.tb02536.x

article 1990

Hysteroscopic follow-up during Tamoxifen treatment

·doi:10.1016/0028-2243(90)90167-y

In order to study the action of Tamoxifen upon the uterus, 16 breast cancer patients were prospectively evaluated by means of an hysteroscopy before Tamoxifen therapy and again after 6 to 36 months of treatment. The results show the occurre…

article 1989

TAMOXIFEN AND THE UTERUS AND ENDOMETRIUM

·doi:10.1016/s0140-6736(89)91741-8